S&P 500 7,561.67 −0.40%
Nasdaq 25,136.27 −0.91%
S&P/TSX 36,105.90 −0.09%
Apple 356.27 +0.39%
Nvidia 162.85 −2.01%
Microsoft 523.88 +0.17%
Shopify 209.74 +0.16%
Royal Bank 288.37 −0.35%
CAD/USD 0.7008 −0.06%
CLOSED · 13:45 ET
Market ClerkRecap
Sat Nov 14 · markets closed3 signals today368 insider buys this week · $138.2MCIRO short report next: Nov 15The week ahead
AJ
INSIDER · CRVS · Corvus Pharmaceuticals, Inc. · CHIEF BUSINESS OFFICER

Arcara Jeffrey

Every open-market transaction filed under this name, Nov 11 to Nov 13.

Filings
4
4 buys · 0 sells
Bought
$50K
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 13CRVSCorvus Pharmaceuticals, Inc.Chief Business OfficerBuy500$10.71$5K—
Nov 13CRVSCorvus Pharmaceuticals, Inc.Chief Business OfficerBuy503$10.37$5K—
Nov 12CRVSCorvus Pharmaceuticals, Inc.Chief Business OfficerBuy497$11.12$6K—
Nov 11CRVSCorvus Pharmaceuticals, Inc.Chief Business OfficerBuy3,000$11.46$34K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.